CD4 and cervical carcinoma: (Dryden-Peterson et al., 2016, Ferreira et al., 2017, Wu et al., 2020) Furthermore, HIV-positive cervical cancer patients might be less likely to receive chemotherapy because of low CD4 cell counts and more likely to experience treatment interruptions.